Antidotes Market Size, Share, Trend Analysis, Segmentation And Forecast To 2033

The antidotes market size has grown strongly in recent years. It will grow from $2.04 billion in 2023 to $2.23 billion in 2024 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to poison control centers, regulatory approvals, industrial and occupational safety, education and training.

The antidotes market size is expected to see strong growth in the next few years. It will grow to $3.27 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to drug overdose crisis, emerging toxins, regulatory support, telemedicine and remote consultation. Major trends in the forecast period include combination antidotes, personalized poison management, digital poison control, pediatric antidotes.

Market Overview -
Antidotes refer to substances or therapeutic interventions designed to counter and alleviate the detrimental impacts of poisons or toxic substances within the body. It is used to mitigate or neutralize the toxic effects of a substance that has entered the body.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=13029&type=smp

Rising Poison Incidents Fuel Expansion Of The Antidotes Market
An increase in poison incidents is expected to propel the growth of the antidotes market going forward. Poison incidents refer to situations where individuals are exposed to, ingest, or come into contact with harmful or toxic substances to their health. Antidotes are critical in poisoning occurrences due to their counteract effects of dangerous substances. The antidote neutralizes, attenuates, or reverses the poison's damaging effects. For instance, in August 2022, according to a report published by The Office for National Statistics, a UK-based government department, in England and Wales, 4,859 drug poisoning-related fatalities were reported in 2021, translating to an annual mortality rate of 84.4 per million inhabitants, an increase of 6.2% from the rate of 79.5 per million in 2020. Therefore, an increase in poison incidents is driving the growth of the antidotes market.

Competitive Landscape -
Major players in the antidotes market are Pfizer Inc., Johnson & Johnson, Merck & Co., Bayer AG, Novartis AG, Bristol Myers Squibb, Alexion Pharmaceuticals Inc., AstraZeneca PLC, Sanofi S.A., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., CSL Behring, Daiichi Sanko Inc., Fresenius Kabi AG, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Ferring B.V., Lupin Limited, Zydus Lifesciences Ltd., Mallinckrodt Pharmaceuticals Ltd., Nichi-Iko Pharmaceutical Co. Ltd., Akorn Incorporated, Meridian Medical Technologies Inc., Alvogen Pharma India Pvt. Ltd., Wockhardt Limited, ADAPT Pharma Inc.

Leading Market Players Innovate With Atropine Sulfate Injections To Enhance Treatment Options In The Antidotes Market
Major market players are concentrating on creating innovative products, such as atropine sulfate injections, to alleviate their market reach and provide better treatment options. Atropine sulfate injection is an antimuscarinic medication that works by inhibiting the action of acetylcholine at parasympathetic nervous system muscarinic receptors. For instance, in August 2022, American Regent Inc., a US-based pharmaceutical company engaged in sterile injectables for healthcare providers, launched an atropine sulfate injection, USP, a traditional injectable drug used as an antisialagogue, an antidote for organophosphorus poisoning or muscarinic mushroom poisoning and to treat bradyasystolic cardiac arrest. It is intended for the temporary blockage of severe or life-threatening muscarinic effects.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/antidotes-global-market-report

Key Segments -
The antidotes market covered in this report is segmented -
1) By Type: Chemical Antidotes; Physical Antidotes; Pharmacological Antidotes; Other Types
2) By Route Of Administration: Injectable; Oral; Capsules And Tablets; Syrup
3) By Application: Animal Bites; Heavy Metal Poisoning
4) By End-User: Hospitals; Homecare; Specialty Clinics; Other End-Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.